EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome

Alexander M Kaizer iD, Annika Winbo iD, Sally-Ann B Clur iD, Susan P Etheridge iD, Michael J Ackerman iD, Hitoshi Horigome iD, Ulrike Herberg iD, Federica Dagradi iD, Carla Spazzolini iD, Stacy A S Killen iD, Annette Wacker-Gussmann iD, Arthur A M Wilde iD und 7 weitere

Europace · 2023

DOI: 10.1093/europace/euad319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2023. Verfasst von Alexander M Kaizer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA. Hauptthemen laut MEDLINE: Heart Rate, Fetal, Long QT Syndrome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NICHD NIH HHS, United States National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In long QT syndrome (LQTS), primary prevention improves outcome; thus, early identification is key. The most common LQTS phenotype is a foetal heart rate (FHR) < 3rd percentile for gestational age (GA) but the effects of cohort, genotype, variant, and maternal β-blocker therapy on FHR are unknown. We assessed the influence of these factors on FHR in pregnancies with familial LQTS and developed a FHR/GA threshold for LQTS. Methods and results In an international cohort of pregnancies in which one parent had LQTS, LQTS genotype, familial variant, and maternal β-blocker effects on FHR were assessed. We developed a testing algorithm for LQTS using FHR and GA as continuous predictors. Data included 1966 FHRs at 7–42 weeks’ GA from 267 pregnancies/164 LQTS families [220 LQTS type 1 (LQT1), 35 LQTS type 2 (LQT2), and 12 LQTS type 3 (LQT3)]. The FHRs were significantly lower in LQT1 and LQT2 but not LQT3 or LQTS negative. The LQT1 variants with non-nonsense and severe function loss (current density or β-adrenergic response) had lower FHR. Maternal β-blockers potentiated bradycardia in LQT1 and LQT2 but did not affect FHR in LQTS negative. A FHR/GA threshold predicted LQT1 and LQT2 with 74.9% accuracy, 71% sensitivity, and 81% specificity.

Conclusion

Genotype, LQT1 variant, and maternal β-blocker therapy affect FHR. A predictive threshold of FHR/GA significantly improves the accuracy, sensitivity, and specificity for LQT1 and LQT2, above the infant’s a priori 50% probability. We speculate this model may be useful in screening for LQTS in perinatal subjects without a known LQTS family history.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Rate, FetalLong QT SyndromeInfantFemalePregnancyHumansGenotypeAdrenergic beta-AntagonistsPhenotypeElectrocardiography

Stichwörter der Autor:innen

BradycardiaChannelopathyFoetal arrhythmiaFoetusInherited arrhythmiasLong QT syndromePotassium currentsStillbirthSudden death

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Clinical Sciences, Pediatrics, Umeå University, Umea, Sweden.
  • Department of Physiology, University of Auckland, Auckland, New Zealand.
  • Department of Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Cardiology, University Medical Center, Amsterdam, The Netherlands.
  • Department of Pediatrics, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT, USA.

ORCID-Profile: Alexander M Kaizer, Annika Winbo, Sally-Ann B Clur, Susan P Etheridge, Michael J Ackerman, Hitoshi Horigome, Ulrike Herberg, Federica Dagradi, Carla Spazzolini, Stacy A S Killen, Annette Wacker-Gussmann, Arthur A M Wilde, Chai-Ann Ng, Annika Rydberg, Peter J Schwartz, Bettina F Cuneo

Förderung

  • NHLBI NIH HHS
  • NICHD NIH HHS
  • United States National Institute of Health
  • Italian Ministry of Health Ricerca Corrente
  • Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death
  • PREDICT2
  • Australian Government’s Medical Research Future Fund
  • Health Research Council of New Zealand

Zitieren

APA

Kaizer, A. M., Winbo, A., Clur, S. B., Etheridge, S. P., Ackerman, M. J., Horigome, H., Herberg, U., Dagradi, F., Spazzolini, C., Killen, S. A. S., Wacker-Gussmann, A., Wilde, A. A. M., Sinkovskaya, E., Abuhamad, A., Torchio, M., Ng, C. A., Rydberg, A., Schwartz, P. J., & Cuneo, B. F. (2023). Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome. Europace. https://doi.org/10.1093/europace/euad319

Vancouver

Kaizer AM, Winbo A, Clur SB, Etheridge SP, Ackerman MJ, Horigome H, et al. Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome. Europace. 2023. doi:10.1093/europace/euad319

BibTeX
@article{Kaizer2023,
  author = {Kaizer, Alexander M and Winbo, Annika and Clur, Sally-Ann B and Etheridge, Susan P and Ackerman, Michael J and Horigome, Hitoshi and Herberg, Ulrike and Dagradi, Federica and Spazzolini, Carla and Killen, Stacy A S and Wacker-Gussmann, Annette and Wilde, Arthur A M and Sinkovskaya, Elena and Abuhamad, Alfred and Torchio, Margherita and Ng, Chai-Ann and Rydberg, Annika and Schwartz, Peter J and Cuneo, Bettina F},
  title = {Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome},
  journal = {Europace},
  year = {2023},
  doi = {10.1093/europace/euad319}
}
Kostenlos starten →